Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

10.29
Delayed Data
As of May 06
 -0.07 / -0.68%
Today’s Change
8.44
Today|||52-Week Range
13.30
+6.63%
Year-to-Date
Greatmark Investment Partners, Inc. Buys Coca-Cola Co, Vanguard Short-Term Bond ETF, PIMCO ...
May 04 / GuruFocus News - Paid Partner Content
Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript
Apr 28 / MotleyFool.com - Paid Partner Content
Amarin (AMRN) Q1 Earnings Top, Vascepa Sales Hit by COVID-19
Apr 29 / Zacks.com - Paid Partner Content
What's Behind Teva's Mixed Q1 Results
Apr 28 / MotleyFool.com - Paid Partner Content
TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down
Apr 29 / Zacks.com - Paid Partner Content
This Risk Might Shock Anyone Holding Johnson & Johnson Stock
Apr 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close10.36
Today’s open10.33
Day’s range10.13 - 10.39
Volume6,238,061
Average volume (3 months)9,414,512
Market cap$11.6B
Data as of 4:00pm ET, 05/06/2021

Growth & Valuation

Earnings growth (last year)-299.46%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.90%
P/E ratioNM
Price/Sales0.63
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
BBIOBridgeBio Pharma Inc-3.35-6.33%
IMMBImmunotech Laborator...0.000.00%
----
BGNEBeigene Ltd+8.60+2.82%
Data as of 3:59pm ET, 05/06/2021

Financials

Next reporting dateAugust 5, 2021
EPS forecast (this quarter)$0.59
Annual revenue (last year)$16.8B
Annual profit (last year)-$4.0B
Net profit margin-23.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts